retatrutide clinical trial retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide what is retatrutide clinical
Description
AgRP is an antagonist of alpha-MSH at MC3Rs and MC4Rs prevents their activation, whereas GABA inhibits the POMC/CART neurons
There are two GLP-1 pills: Wegovy (semaglutide) was the first GLP-1 pill approved for weight loss in December 2025
A major driver is the sunset of the enhanced premium tax credits, which had held subsidized Marketplace premiums steady in 2024 and 2025
This level of demand means benefit managers can no longer treat GLP1 coverage as a niche policy question
